The global active pharmaceutical ingredients (API) market is
expected to reach a value of USD 239.8 billion by 2025, based on a new report
by Grand View Research, Inc. The rising prevalence of lifestyle-induced &
age-related diseases and cancer is projected to drive the market over the
forecast period. Advancements in recombinant molecular technologies and high
capitalization for development of novel drugs are also estimated to boost
growth.
Favorable government initiatives for increasing focus toward
generic drugs is a key factor for market growth. Decrease in generic drug
prices, higher acceptance in low income and decrease in reimbursement for branded
drugs are the recent trends in the market affirming growth of generic
drugs.
Browse full research report on Active Pharmaceutical
Ingredients (API) Market: http://www.grandviewresearch.com/industry-analysis/active-pharmaceutical-ingredients-market
Further Key Findings from the Study Suggest:
- Synthetic
APIs was the largest segment by revenue share in 2015 owing to high
demand.
- Biotech
APIs are estimated to grow lucratively over the forecast period with high
R&D initiatives being undertaken for their development
- Captive
manufacturers, being the conventional option of API manufacturing, held
the majority of the share.
- On the
other hand, the merchant manufacturers segment is expected to be
fastest-growing due to growing outsourcing activities
- Generic
APIs will experience lucrative growth over the forecast period attributed
to patent expirations of branded drugs
- APIs
are identified to have highest application in cardiovascular therapeutics.
Increasing mortality caused by heart diseases and growing demand for
fast-acting drugs are the major factors contributing to dominance
- North
America dominated in terms of revenue share in 2015 and Asia Pacific is
expected to grow at a significant growth rate over the forecast period
- Some
of the major companies in the API market are AbbVie, Inc., Boehringer
Ingelheim GmbH, Cipla, Inc., and Merck & Co., Inc.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the API market by type of
synthesis, type of manufacturer, type, applications, and region:
API Type of Synthesis Outlook (Revenue, USD Billion, 2014
- 2025)
- Biotech
- Monoclonal
antibodies
- Recombinant
proteins
- Vaccines
- Synthetic
API Type of Manufacturer Outlook (Revenue, USD Billion,
2014 - 2025)
- Captive
APIs
- Merchant
APIs
API Type Outlook (Revenue, USD Billion, 2014 - 2025)
- Generic
APIs
- Innovative
APIs
API Application Outlook (Revenue, USD Billion, 2014 -
2025)
- Cardiovascular
Disease
- Oncology
- CNS
& Neurological Disorders
- Orthopedic
Disorders
- Endocrinology
- Pulmonology
- Gastrointestinal
Disorders
- Nephrology
- Ophthalmology
API Regional Outlook (Revenue, USD Billion, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- China
- Japan
- Latin
America
- Mexico
- Brazil
- MEA
- South
Africa
Access press release of this research report by Grand
View Research: http://www.grandviewresearch.com/press-release/global-active-pharmaceutical-ingredients-api-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports,
customized research reports, and consulting services. To help clients make
informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
For more information:
www.grandviewresearch.com
No comments:
Post a Comment